84-4451-72 TEM7 (Tumor Endothelial Marker 7, Plexin Domain Containing 1, Plexin Domain-containing Protein 1 Precursor, PLXDC1, Tumor Endothelial Marker 3, TEM3) (APC) 100ul T2500-01C-APC
特徴
- Tumor endothelial marker 7 (TEM7) is a 55.8kD protein belonging to the plexin family.
- TEM7 is strongly expressed in endothelial cells from colorectal cancer and from primary cancers of the lung, liver, brain, breast and pancreas.
- High expression of TEM7 is associated with metastasis and poor survival of patients with osteogenic sarcoma.
- Studies have indicated the existence of least four isoforms of TEM7 which include membrane bound, secreted and intracellular forms.
- TEM7 is not detectable in endothelial cells from normal tissues.
- Applications:Suitable for use in Immunohistochemistry (paraffin) and Western Blot.
- Other applications not tested.
- Recommended Dilution:Immunohistochemistry (paraffin): 2.5ug/mlWestern Blot: 0.5-1ug/mlOptimal dilutions to be determined by the researcher.
- Storage and Stability:Store product at 4°C in the dark.
- DO NOT FREEZE! Stable at 4°C for 12 months after receipt as an undiluted liquid.
- Dilute required amount only prior to immediate use.
- Further dilutions can be made in assay buffer.
- Caution: APC conjugates are sensitive to light.
- For maximum recovery of product, centrifuge the original vial prior to removing the cap.
- Note: Applications are based on unconjugated antibody.
仕様
- Size:100ul
- Host:rabbit
- Source Antibody:human
- Grade:Affinity Purified
- Purity:Purified by immunoaffinity chromatography.
- Form:Supplied as a liquid in PBS, pH 7.2. Labeled with Allophycocyanin (APC).
- Specificity:Recognizes human TEM7. Species Crossreactivity: mouse, rat.
- Isotype:IgG
- Immunogen:A peptide corresponding to a 16aa sequence from near the center of human TEM7.
- Shelf Life:1year
- EU Commodity Code:30021010
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]